These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 24975605)

  • 1. Oligonucleotides and G-quadruplex stabilizers: targeting telomeres and telomerase in cancer therapy.
    Crees Z; Girard J; Rios Z; Botting GM; Harrington K; Shearrow C; Wojdyla L; Stone AL; Uppada SB; Devito JT; Puri N
    Curr Pharm Des; 2014; 20(41):6422-37. PubMed ID: 24975605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligonucleotides Targeting Telomeres and Telomerase in Cancer.
    Schrank Z; Khan N; Osude C; Singh S; Miller RJ; Merrick C; Mabel A; Kuckovic A; Puri N
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30189661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Telomere-Related Pharmacological Targets.
    Berei J; Eckburg A; Miliavski E; Anderson AD; Miller RJ; Dein J; Giuffre AM; Tang D; Deb S; Racherla KS; Patel M; Vela MS; Puri N
    Curr Top Med Chem; 2020; 20(6):458-484. PubMed ID: 31916516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating Cancer by Targeting Telomeres and Telomerase.
    Ivancich M; Schrank Z; Wojdyla L; Leviskas B; Kuckovic A; Sanjali A; Puri N
    Antioxidants (Basel); 2017 Feb; 6(1):. PubMed ID: 28218725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting telomeres and telomerase.
    De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
    Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel anticancer therapeutics targeting telomerase.
    Ruden M; Puri N
    Cancer Treat Rev; 2013 Aug; 39(5):444-56. PubMed ID: 22841437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
    Kelland LR
    Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to inhibit telomerase activity for cancer therapy.
    Kyo S; Inoue M
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):613-26. PubMed ID: 12678728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting human telomerase in cancer therapy.
    Huard S; Autexier C
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):577-87. PubMed ID: 12678725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent patents on anti-telomerase cancer therapy.
    Agrawal A; Dang S; Gabrani R
    Recent Pat Anticancer Drug Discov; 2012 Jan; 7(1):102-17. PubMed ID: 21854360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.
    Rankin AM; Faller DV; Spanjaard RA
    Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomere maintenance as a target for drug discovery.
    Sekaran V; Soares J; Jarstfer MB
    J Med Chem; 2014 Feb; 57(3):521-38. PubMed ID: 24053596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the molecular design of potential anticancer agents via targeting of human telomeric DNA.
    Maji B; Bhattacharya S
    Chem Commun (Camb); 2014 Jun; 50(49):6422-38. PubMed ID: 24695755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crossroads of telomere biology and anticancer drug discovery.
    Seimiya H
    Cancer Sci; 2020 Sep; 111(9):3089-3099. PubMed ID: 32579791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting telomerase and telomeres: a click chemistry approach towards highly selective G-quadruplex ligands.
    Moorhouse AD; Haider S; Gunaratnam M; Munnur D; Neidle S; Moses JE
    Mol Biosyst; 2008 Jun; 4(6):629-42. PubMed ID: 18493662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling the regulation of telomere length: the effects of telomerase and G-quadruplex stabilising drugs.
    Hirt BV; Wattis JA; Preston SP
    J Math Biol; 2014 May; 68(6):1521-52. PubMed ID: 23620229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
    Tárkányi I; Aradi J
    Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere targeting with a novel G-quadruplex-interactive ligand BRACO-19 induces T-loop disassembly and telomerase displacement in human glioblastoma cells.
    Zhou G; Liu X; Li Y; Xu S; Ma C; Wu X; Cheng Y; Yu Z; Zhao G; Chen Y
    Oncotarget; 2016 Mar; 7(12):14925-39. PubMed ID: 26908447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomeres as targets for anticancer therapies.
    Folini M; Venturini L; Cimino-Reale G; Zaffaroni N
    Expert Opin Ther Targets; 2011 May; 15(5):579-93. PubMed ID: 21288186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G-quadruplex stabilizer Tetra-Pt(bpy) disrupts telomere maintenance and impairs FAK-mediated migration of telomerase-positive cells.
    Shen Z; Zheng R; Yang H; Xing S; Jin X; Yan H; Zhu J; Mei Y; Lin F; Zheng X
    Int J Biol Macromol; 2022 Jul; 213():858-870. PubMed ID: 35697164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.